Monday, 3 February 2020

Automatic Pill Dispenser Market Research Report 2019 Analysis and Forecast to 2024

The Global Automatic Pill Dispenser Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 1,700 million in 2018 and is projected to register a CAGR of 7.3% over the forecast period.
The increasing prevalence of cardiovascular disorders and growing older population are the key factors driving the automatic pill dispenser market size. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.
Various other factors such as the advancements in automatic pill dispenser, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on home care centers are also expected to propel the growth of the market.
However, the high cost of the system can hamper market growth over the forecast period.
Key Players:
Some of the key players in the global automatic pill dispenser market are Baxter International Inc, Becton, Dickinson and Company, Cerner Corporation, Capsa Healthcare, McKesson Corporation, Omnicell Inc., ScriptPro LLC, Swisslog Holdings AG, Yuyama Co.Ltd. Talyst, Inc., and others
Segmentation:
The global automatic pill dispenser market is segmented based on type, end user, and region.
The global market for automatic pill dispenser, by type, is segmented into a centralized, automated dispensing system, and decentralized the automated dispensing system. The centralized, automated dispensing system is further classified into robotic automated dispensing systems, and carousels. Furthermore, decentralized automated dispensing system is classified into a pharmacy-based automated dispensing system, ward-based automated dispensing system, and automated unit dose dispensing system.
Based on end user, the market is segmented into hospital pharmacy, retail pharmacy, and home healthcare.
In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.
The automatic pill dispenser market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European automatic pill dispenser market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The automatic pill dispenser market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The automatic pill dispenser market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Analysis:
The Americas dominated the global market for automatic pill dispenser owing to the rising geriatric population within the region. As per the data suggested by the United Census Bureau, by 2060, the US is projected to grow by 79 million people, from about 326 million today to 404 million. The population is projected to cross the 400-million threshold in 2058. Additionally, according to the WHO, in the US, more than 20% of the total population is likely to be aged 65 years or over by 2030. Rising participation of market players is also strongly impacting the growth of the Americas automatic pill dispenser market. Moreover, the rising prevalence of chronic disorders such as cardiovascular disorders, cancer, diabetes, and others are driving the growth of the market. For instance, according to the National Cancer Institute, in 2016, in the US, 15.5 million new cases of cancer were registered, and approximately USD 147.3 billion were spent for cancer care.
In 2018, it was estimated that Europe stood second in the global automatic pill dispenser market. Technological advancements, along with the availability of funding opportunities in research and innovation, will support market growth.
Asia-Pacific (APAC) is expected to represent the phenomenal market growth throughout the forecast period due to rising prevalence of chronic conditions, growing awareness about medications, and increasing healthcare expenditure. During 2016-2017, Australia spent nearly USD181 billion on health, which is more than USD 7,400 per person and 10% of overall economic activity.
On the other hand, the Middle East and Africa held the least share in the global automatic pill dispenser market due to the low economic development, especially within the African region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future      
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028         
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:
Labels:

Global Handheld Surgical Devices Market Production, Capacity, Revenue, Price, Gross Margin Analysis and forecast 2019-2023

Worldwide handheld surgical devices market size is likely to prosper substantially over the forecast period. It is projected to grow at a CAGR of 6.8% over the forecast period 2018–2023.
Handheld surgical devices are specifically designed devices and is extensively preferred by doctors. The device enables them to perform surgeries with high precision. Demand for surgeries has escalated globally since it has become the standard treatment procedure for treating complex health conditions. Despite the eminent advantages of minimally invasive surgery (MIS) to the patients, the technique is associated with certain technical challenges for surgeons. With the introduction of laparoendoscopic single-site (LESS) surgery, the technical challenges of MIS became prominent. New handheld surgical devices have been industrialized to curtail the limitations posed by minimally invasive procedures. The handheld surgical devices provide enhanced functionalities along with articulating and precision-driven instrument tips. Additionally, the rising demand for surgical procedures act as a significant factor in driving the handheld surgical devices market. Besides, high geriatric population, the rising incidence of accidents, technological upgradations, surging demand for reconstructive & plastic surgery, and increasing patient awareness about the applications of handheld surgical devices likely to boost the handheld surgical devices market. For instance, in 2017, the launch of Vscan Extend by GE positively impacted the global handheld surgical devices market. Vscan Extend is a portable ultrasound device introduced by GE. It is employed for monitoring heart failure patients and in measuring bladder volume. However, lack of trained physicians coupled with stringent government regulations can hinder the market growth over the forecast period. Moreover, the side effects associated with surgeries and implementation of Protection and Affordable Care Act in the U.S. are likely to challenge the growth of the handheld surgical devices market considerably.
Market Segmentation
Global handheld surgical devices market has been segmented based on product, application, and end user. Based on product, the handheld surgical devices market has been segmented into spatulas, forceps, dilators, retractors, cutter devices, auxiliary devices, graspers, and others. The auxiliary devices segment has been sub-segmented as cannulas, closure, and clamps devices. The cutter devices segment has been sub-segmented as lancets, scissor, and trocars. The others segment consists of curettes, punches, snares, and blunt dissectors. Based on application, the market has been segmented into urology, neurology, orthopedics, gynecology, cardiovascular, wound closure, and others. Based on end user, the market has been segmented into clinics, hospitals, research and academic institutes, ambulatory surgical centers, and others. Clinics represented a promising market share in 2017 owing to the growing prevalence of chronic conditions.
Regional Analysis
The Americas held the largest worldwide market share for handheld surgical devices owing to increasing geriatric population and the surging incidences of chronic ailments. The Centers for Disease Control and Prevention (CDC) reported that in 2016, almost 28.1 million adults were diagnosed with heart disease in the United States. In 2017, Europe held the second largest share in the global handheld surgical devices market. The prosperity of the market is owing to the growing instances of surgical procedures collectively with increasing investments in research and development. In 2017, Asia-Pacific represented the fastest growing market in the handheld surgical devices industry. Improving healthcare conditions, emerging brands within the market, surging healthcare expenses, and rising number of surgical procedures, make Asia Pacific a lucrative market for the handheld surgical device manufacturers.
Key Players
The global handheld surgical devices market is dominated by efficient players such as Integra LifeSciences Corporation, B. Braun Melsungen AG, Pelion Surgical, Smith & Nephew, Thompson Surgical, CooperSurgical Inc., Stryker, Dickinson and Company (BD), Millennium Surgical Corp, Becton, KLS Martin, Aspen Surgical, Medtronic, Johnson & Johnson, Elite Medical, Medicon Eg, Zimmer Biomet Holdings, and others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Surgical Drills Market Revenue, Opportunity, Forecast and Value Chain Analysis 2019

Global Surgical Drills Market Research Report: by Product (pneumatic drills, electric drills, and others), By Application (orthopedic surgery, neurosurgery, dental surgery, and others) By End-user (Hospitals & clinics, and others) -Forecast Till 2023
An expert on premium research reports, Market Research Future asserts that the, Global Surgical Drills Market is expected to grow significantly over the forecast period. The market held a market value of USD 463.64 million in 2017 and is projected to grow at a CAGR of 4.93% over the forecast period.
Surgical drills as the name itself suggests, are drill machines which are used during the various surgical procedures. Their main function is to drill, cut, and bore holes in the bone in order to attach surgical pins, plates, or screws. There are several types of surgical drills available which are powered by different source. These include pneumatic drills, electric drills, and battery powered drills among others. Surgical drills have simplified the tedious job of a surgeon and reduced the surgery time significantly. Surgical drills have become an important tool in the surgical procedures. Due to high surgical drills market demand and Increasing number of orthopedic and dental surgeries, high awareness about the dental hygiene and high disposable income are some of the factors contribute to the growth of the surgical drills market size.
Key players:
Adeor medical AG, AlloTech Co.Ltd. Arthrex Inc., B.Braun Melsungen AG, CONMED Corporation, De Soutter Medical, DePuy Synthes, Medtronic plc, Stryker Corporation and Zimmer Biomet Holdings, Inc. are some of the key players in the global surgical drills market.
Segmentation:The Global Surgical Drills Market has been segmented into product, application and end-user.Based on products, the market has been segmented into, pneumatic drills, electric drills, battery powered drills, accessories, and others. The pneumatic drills segment is expected to account for the largest share in the global surgical drills market in 2017. This large share is majorly attributed to the wider acceptance of the devices, and better patient compliance as compared to other products. Based on application, the market has been segmented into orthopedic surgery, neurosurgery, ENT, dental surgery, and other. The orthopedic surgery segment is expected to account for the largest share in the global surgical drills market in 2017 followed by dental surgery segment.Based on end-users, the market has been segmented into hospitals & clinics, ambulatory surgical centers, academic and research institutes, and others. The hospitals & clinics segment is expected to account for the largest share in the global surgical drills market in 2017. At the same time, the increasing establishments of the ambulatory surgical centers in the developed and developing countries has led this segment to grow at the fastest rate during the forecast period.
Based on the regions, the market for surgical drills is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical drills market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.European surgical drills market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The surgical drills market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical drills market in the Middle East & Africa has been segmented into regions such as the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global surgical drills market owing to the rising number of the orthopaedic surgeries, increasing awareness about dental hygiene leading to increase in dental procedures and surgeries. The development of the better surgical approaches and advanced treatment procedures have affected the growth of the American market in a positive way. Moreover, high awareness among American population, state of the art medical infrastructure, high disposable income, are some of the many factors that drive the growth of the surgical drills market in this region.
Europe is expected to hold the second largest market share in the global surgical drills market. The market growth in this region is majorly attributed to the increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the surgical drills market owing to the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East & Africa region is anticipated to show minor growth opportunities in the surgical drills market during the forecast period.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Laser Probe Market Growth and Restrain Factors Analysis By 2023

Market Analysis 
The global laser probe market is predicted to touch USD 1560.76 million at a 9.11% CAGR between 2018-2023, reveals the latest Market Research Future (MRFR) report. Laser probe, simply put, is an ophthalmic medical device that has been designed for various diagnostic applications. This diagnostic procedure is minimally-invasive, where the laser probes aid in detecting the abnormalities, if any, in the brain, eye, and other areas. The laser probe assists in the real-time determination of abnormalities instead of extracting samples from patients and conducting different diagnostic procedures on it. It leads to better efficiency of treatment as well as reduced time taken for determining the outcomes of the procedure. 
Various factors are propelling the laser probe market growth. These factors, as stated by the latest Market Research Future (MRFR) report, include rising prevalence of cases where laser probes are needed, increasing incidence of ophthalmic disorders/diseases owing to growing number of diabetic patients, growing geriatric population, increasing incidence of medical emergencies, and increasing number of glaucoma and cataract surgeries. Additional factors pushing market growth include rising prevalence of chronic diseases, especially prostate cancer, barrette’s esophagus, non-melanoma skin cancer, and diabetic retinopathy, among others, technological innovations and improvements in reimbursement protocols. 
On the flip side, the availability of alternative devices and technologies in the market and absence of technically skilled experts to use such devices are factors that may impede the laser probe market growth over the forecast period. 
Market Segmentation 
The Market Research Future report provides an all-inclusive segmental analysis of the laser probe market trends, growth and study on the basis of end user, application, product type, and probe type. 
Based on product type, the laser probe market is segmented into continuous-wave laser probes, pulsed laser probes, and others. Of these, the continuous-wave laser probes segment will have the largest share in the market over the forecast period. It is widely used in different dermatological procedures, including marks or scars removal, and wrinkle reduction. 
Based on the probe type, the laser probe market is segmented into a single laser probe, cluster laser probe, and others. Of these, the single laser probe segment will dominate the market over the forecast period. 
Based on the application, the laser probe market is segmented into rheumatology, dentistry, ophthalmology, orthopedics, dermatology, and others. Of these, the ophthalmology segment will lead the market over the forecast period, followed by the dermatology segment. 
Based on the end user, the laser probe market is segmented into tertiary hospitals, clinics, and others. Of these, the tertiary hospitals segment will have the maximum share in the market over the forecast period owing to the rapid proliferation of tertiary hospitals both in suburban and urban areas. 
Regional Analysis 
By region, the laser probe market report covers the latest trends and growth opportunities across the Americas, the Middle East and Africa, Europe, and the Asia Pacific. Of these, the Americas will remain the driving force in the market during the forecast period chiefly on account of the burgeoning demand for minimally invasive cosmetic surgeries, arthritis treatment, and cataract procedures. This will be followed by Europe, which is predicted to have the second-largest share in the market over the forecast period. 
Key Players 
Major players profiled in the laser probe market report include Quantel Medica, Iridex Corporation, Vitreq, OphthalMed LLC, Lumenis, Transonic Systems Inc., ADInstruments, Reimers & Janssen GmbH, Omega Laser Systems Limited, FCI, Bausch & Lomb Incorporated, and Alcon (Novartis). Key players have used multiple strategies to create a foothold in the market, such as expansions, partnerships, acquisitions, and more. 
Industrial News
March 2019: Researchers in Canada have created a laser probe that utilizes changes in light patterns for detecting melanoma, one of the deadliest skin cancers. The researchers claimed that this laser probe could offer a numerical result that is easily understandable akin to the principal of a thermometer. Irrespective of its usability and low cost, this device is a clinical tool to diagnose melanoma instead of being a consumer product. 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Duodenal Cancer Market 2019 Share, Trend, Segmentation and Forecast to 2023

Market Overview
The worldwide duodenal cancer market is anticipated to develop gradually over the forecast period. The global duodenal cancer market is estimated to record a CAGR of 3.2% over the forecast period of 2018–2023.
It is a rare kind of cancer that develops in the uppermost part of the small intestine. As the cancer cells start generating in the duodenum, it develops tumors. The tumors block food from passing through the digestive tract. At this point, the body or the small intestine is unable to extract the essential vitamins. The patient experiences a number of symptoms.
Symptoms can be ambiguous, which makes early diagnosis difficult. Duodenum plays a significant role in the digestive system. Bile and chemical secretions are passed through duodenum which helps the food to break down. Duodenal cancer disrupts the digestive process and prevents the body from absorbing essential minerals. Several diagnoses have managed to detect it at an early stage. Tests that capture detailed images of the GI tract, such as a CT scan or MRI, tests such as endoscopy, that examines the inner surface of the GI tract with the help of a flexible pipe with an attached small camera or the technique widely known as biopsy where a part of tissue is eliminated for analysis, could help the patient with the early detection of the disease.
Rising prevalence of chronic ailments, increasing instances of rare cancers, increasing geriatric population, and technological advancements are projected to stimulate the market growth. In January 2018, for instance, GE Healthcare entered into a long-term partnership with Roche Diagnostics to co-create and promote digital medical decision support services. With this, the firms will primarily focus on solutions that improve and accelerate personalized treatment options for critical care patients.
Furthermore, increased healthcare investment is likely to influence the worldwide duodenal cancer market size. However, strict administrative regulations for product approval and expensive treatments are major factors undermining the market potential.
Market Segmentation
The worldwide duodenal cancer market has been segmented based on treatment, diagnosis, and type.
Based on treatment, the market has been segmented into chemotherapy, radiotherapy, and surgery.
Based on diagnosis, the market has been segmented into capsule endoscopy, colonoscopy or endoscopy, MRI scan, CT scan, barium X-ray, and other tests.
Based on type, the global duodenal market has been segmented into sarcoma, adenocarcinoma, lymphoma, and neuroendocrine (carcinoid) tumors.
Regional Analysis
The Americas lead the worldwide duodenal cancer market owing to factors such as high healthcare expenditure, growing incidences of chronic & rare ailments, and access to well-established healthcare system. The American Society of Clinical Oncology (ASCO) recorded in January 2018 that 60% of the population had been diagnosed with duodenal cancer at the distant or initial phase. Europe holds the second-largest market share on account of the healthcare supports provided by the government coupled with the occurrences of several chronic ailments. The Asia-Pacific market is likely to be driven by factors such as surge in disposable income, government funding for healthcare units and growing prevalence of chronic diseases. MEA accounts for the smallest share of the global duodenal cancer market. The market growth in this region can be attributed to the improving healthcare set-up and increasing investment in the healthcare sector.
Key Players
The key players in the worldwide duodenal cancer market includes Pfizer Inc., Eli Lilly & Company, Bristol-Myers Squibb Company, AbbVie, Inc., F. Hoffman-La Roche Ltd., Novartis AG, Thermo Fisher Scientific, Bayer AG, Boehringer Ingelheim International GmbH, Ipsen Biopharmaceuticals Inc., Abbott, G E Healthcare, AstraZeneca, Agilent Technologies Inc., Dickinson & Company, and Becton.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Bone Implant Market Trends and Drivers Analysis 2019 To 2023

Americas to Dominate Bone Implant Market due to High Availability of Advanced Technology
The global bone implant market share is expected to rise at a CAGR of 6.8% over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global bone implant market is mainly driven by the growing technological advancement in bone implants, which has led to the availability of a number of viable options in the bone implants market, and the growing need for bone implant procedures around the world. The rising prevalence of sports injuries and other bone injuries is also likely to be a major driver for the global bone implant market over the forecast period.
Rapid advancement of the technology around bone implants is likely to be a major driver for the global bone implant market over the forecast period. With time, the global bone implants market has grown rapidly, leading to steady development of a number of products that can be viably used as bone implants. The steady development of the materials industry has also led to a rapid rise for the global bone implants market, as a number of viable materials have been developed that can be used to produce effective bone implants. This is likely to remain a major driver for the global bone implants market over the forecast period, as the material plays a key part in ensuring long-term viability of the bone implant. Materials such as ceramics and polymers are likely to undergo extensive research in the coming years, leading to steady growth of the bone implant market.
On the other hand, the high prices of orthopedic surgeries and bone implant products could hinder the global bone implant market’s growth over the forecast period. Government policies could also hinder the use of specific products in the global bone implant market over the forecast period.
Competitive Analysis:
Leading players in the global bone implant market include Depuy Synthes Inc., NuVasive Inc., Stryker Corporation, Integra LifeSciences Holdings Corporation, The Orthopedic Implant Company, Aesculap Implant Systems, Conmed Corporation, Arthrocare Corporation, BioTek Instruments Inc., Wright Medical Group N.V., Medtronic plc, Zimmer Biomet Holdings Inc., Smith & Nephew plc, and Globus Medical Inc.
Acquisitions and mergers and likely to remain a popular tactic for players in the global bone implant market over the forecast period.
In May 2018, NN Inc. acquired Paragon Medical for USD 375 million.
In 2017, Stryker Corporation acquired Vexim for USD 215 million.
Segmentation:
The global bone implant market has been segmented on the basis of biomaterial, product, application, device, end user, and region.
On the basis of biomaterial, the bone implant market has been classified as metals, ceramics, and polymers. The metal segment has been further divided into titanium, stainless steel, cobalt chromium alloy, gold alloys, and tantalum. The ceramics segment has been further divided into alumina, hydroxyapatite, beta-tricalcium, phosphate, carbon, bioglass, zirconia, and zirconia-toughened alumina. The polymers segment has been sub-segmented into polymethylmethacrylate, polytetrafluoroethylene, polyethylene, polysulfone, polyurethane, and polyether ether ketone.
By product, the market is segmented into orthopedic screws, orthopedic plates, interlocking nails (rods), and others.
By application, the bone implant market is segmented into hip orthopedic implants, knee orthopedic implants, spine orthopedic implants, dental orthopedic implants, and others.
By device, the market is segmented into external fixators and internal fixators.
By end user, the market is segmented into orthopedic clinics, hospitals, and others.
Regional Analysis:
The Americas is likely to remain the major regional party in the global bone implant market over the forecast period. The advanced healthcare sector in the region, the high disposable income of consumers in developed countries such as the U.S. and Canada, and the growing prevalence of sports injuries in the region are likely to drive the bone implant market in the Americas region over the forecast period.
The rising prevalence of orthopedic diseases in Europe is likely to drive the regional market for bone implants over the forecast period. Asia Pacific is also likely to exhibit a rapid growth in the bone implant market over the forecast period due to the growing prevalence of orthopedic conditions.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Acoustic Neuroma Market Therapeutics in Global Markets to 2023 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

The global acoustic neuroma market is growing pervasively, mainly due to the rising prevalence of the condition. There are several proven, effective therapeutics and devices to treat acoustic neuroma are available in the market, which is a major factor driving the growth of the market. Indeed, technological advancements transpired in medical science and biotechnology is a key driving force behind the growth of the market, improving the outlook for the treatments.
According to a leading research firm - Market Research Future (MRFR), the global acoustic neuroma market size is expected to garner massive accruals by 2023. In its recently published analysis, MRFR also asserts that the market would register a CAGR of approximately 7.6% throughout the forecast period (2017-2023).  Improving economic conditions are playing a pivotal role in the growth of the market, increasing the purchasing power of people, and access to quality healthcare.
Factors such as increasing per capita health care expenditures, governmental initiatives, spreading awareness towards the availability of novel treatment procedures to manage the condition are substantiating the growth of the market. Rising demand for new techniques for the diagnosis and advancements in surgical procedures fuel the growth of the market. 
Conversely, the high cost associated with the treatment & devices, alongside, the long approval time for the clinical trials are obstructing the growth of the market. Nevertheless, factors such as the large unmet needs especially in the developing regions would support the market growth over the assessment period, providing ample scope to the market to evolve further and prompting substantial investments for R&D to bring more novelty and betterments in the imaging techniques.
Global Acoustic Neuroma Market – Segments
The report is segmented into six market dynamics to widen the scope of understanding,
By Type                : Unilateral Vestibular Schwannomas and Bilateral Vestibular Schwannomas.
By Diagnosis      : Hearing Test (audiometry), Electronystagmography, and Magnetic Resonance Imaging (MRI), among others.
By Treatment    : Monitoring, Surgery, Radiation Therapy, and Supportive Therapy, among others.
By Drug Class     : Anticonvulsants, Corticosteroids, Osmotic Diuretics, and Pain Killers, among others.
By End-user                        : Hospitals, Diagnostic Centers, and Academic & Research Institutes, among others.
By Regions                          : Europe, North America, Asia Pacific, and the Rest-of-the-World.

Global Acoustic Neuroma Market – Geographical Analysis
North America dominates the global acoustic neuroma market with the largest market share. The presence of large numbers of notable players and diagnostic centers alongside, greater governmental emphasis on disease prevention & wellness foster the regional market growth. Moreover, substantial investments in R&D activities to develop novel therapies and breakthrough medicines drive the growth of the regional market.
Healthcare facilities in the US are gradually moving from treatments to wellness; as a result, the prevention and early detection of the disease become crucial. The US acoustic neuroma market, heading with the increasing diagnosed cases accounts for the largest share in the regional market. The rising prevalence of acoustic neuroma lifestyle fosters the market growth in the region.
The acoustic neuroma market in the European region is another lucrative market. Increasing numbers of cases alongside, the proliferation of advanced treatment facilities and availability of skilled medical professionals drive the market in the region. Moreover, the increasing government support for research & development, technological advancements, and well-spread awareness among people towards the availability of treatments for the condition support the regional market growth.
The Asia Pacific acoustic neuroma market is emerging as a rapidly growing market, globally. Factors substantiating the growth of the regional market include the increasing prevalence of acoustic neuroma, spreading awareness among people about the conditions, and the availability of new treatments to manage the condition. Growing markets in China and India contribute to the regional market growth majorly.
Global Acoustic Neuroma Market – Competitive Landscape
Fiercely competitive, the acoustic neuroma market appears to be fragmented due to the presence of many well-established players. These players, along with small players and new entrants, form a competitive edge in the market. To gain a competitive advantage in the market, these players incorporating strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product/technology launch. Substantial investments are transpired in R&D to bring innovations in the therapy and clinical trials.
Major Players:
Players leading the global acoustic neuroma market include Siemens Healthcare (US), GE Healthcare (US), Philips Healthcare (US), Toshiba Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), F. Hoffmann-La Roche AG (Switzerland), Novartis AG (Switzerland), Merck & Co., Inc. (US), and Pfizer Inc. (US), among others.
Industry/ Innovation/Related News:
July 22, 2019 ----- Med-El Corporation (the US), a leading global medical device company specializing in the development and manufacturing of implantable hearing solutions and speech processors announced receiving of the US FDA approval for its Cochlear Implants for single-sided deafness (SSD) and asymmetric hearing loss (AHL). Cochlear implants from MED-EL are the world’s most innovative devices helping children and adults with hearing loss hear life again. This is the first time ever that cochlear implants have been approved for these indications in the United States.
Contraindications for SSD and AHL are the same as for individuals receiving cochlear implants who have bilateral hearing loss, if the individual is known to be intolerant of the materials used in the implant and if an individual has an acoustic neuroma, and others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)